Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease and have a worse prognosis after percutaneous coronary interventions (PCI). The BioFreedom polymer-free biolimus-A9-eluting stent (PF-BES) has shown promising results in patients at high bleeding risk; however, its performance in CKD patients has yet to be analyzed.
Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry. Chiarito M, Sturla M, Briguori C, Mancone M, Tamburino C, Fabbiocchi F, Trabattoni D, Tomai F, Paggi A, Gioffrè G, Sclafani R, Giordano A, Stefanini GG, Sardella G. J Cardiovasc Med (Hagerstown). 2021 Oct 8. doi: 10.2459/JCM.0000000000001269